Business / Finance

RSS

NorthStar Healthcare invests over $170M In two healthcare real estate transactions

NorthStar Healthcare Income, Inc. (NorthStar Healthcare) announced that it recently invested more than $170.0 million in two healthcare real estate transactions, including one assisted living portfolio acquisition and one mezzanine loan backed by a portfolio of skilled nursing and assisted living facilities.

7 Oct 2014

Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Avidity NanoMedicines today announced that it has expanded its investor syndicate through the closing of a $6 million convertible note financing co-led by Fidelity Biosciences and TPG Biotech.

7 Oct 2014

Cardiac Dimensions adds $8.5M to its previously announced financing

Cardiac Dimensions® today announced the addition of $8.5 million to its previously announced financing.

7 Oct 2014

COMS Interactive, PointRight partner to integrate advanced clinical services and predictive analytics

PointRight Inc., the industry-standard analytics leader for healthcare providers and payers, and COMS Interactive, also known as Clinical Outcomes Management Systems, the leading disease management software provider in the post-acute care marketplace, announce that the two companies will leverage their collective clinical strengths and sales and marketing resources.

7 Oct 2014

Cognizant announces acquisition of Cadient Group

Cognizant today announced it has acquired Cadient Group, a full-service digital marketing agency that serves a broad spectrum of life sciences companies in the pharmaceutical, biotechnology, consumer health, and medical device industries.

7 Oct 2014

SynGen announces securement of additional financing from San Francisco-based life sciences venture capital firm

SynGen, Inc., a company that focuses on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has secured additional financing from Bay City Capital, LLC, a San Francisco-based life sciences venture capital firm.

6 Oct 2014

Bitplane and microDimensions announce partnership to bring Voloom to the wider life sciences market

Bitplane, an Oxford Instruments company and microDimensions today announce a partnership to bring Voloom, from microDimensions, to the wider life sciences market via the Bitplane sales channels.

From microDimensions - Bramlage Scientific GmbH 3 Oct 2014

BioCap conference showcased life sciences companies in the North

The unique BioCap conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, was a great success, combining the forces of science and financial investment enabling businesses from all over the North to secure essential funding.

3 Oct 2014

Sigma-Aldrich enters into agreement to acquire Cell Marque to better serve IHC customers

Sigma-Aldrich Corporation announced today that it has entered into an agreement to acquire Rocklin, California, based Cell Marque Corporation in a move to strengthen its antibody portfolio and to better serve immunohistochemistry (IHC) customers.

3 Oct 2014

Cepheid to acquire LABSCO's customer relationships for $21M

Cepheid today announced that, effective today, it has entered into a purchase agreement to acquire the customer relationships from its former distribution partner, the Laboratory Supply Company (LABSCO).

3 Oct 2014

Ganymed, BioNTech AG open new headquarters and research facility in Germany

BioNTech AG and Ganymed Pharmaceuticals AG, two premier German biotechology companies, announced today the joint- opening of a new approx. 10,000 square-meters (108,000 square-feet) headquarters and research facility.

1 Oct 2014

GSK awards milestone payment to Isis Pharmaceuticals to develop ISIS-GSK4Rx for ocular disease

Isis Pharmaceuticals, Inc. announced today that it has earned a $1.5 million milestone payment from GSK related to the advancement of the program to develop ISIS-GSK4Rx to treat an undisclosed ocular disease.

1 Oct 2014

Cardinal Health releases 2014 digital report and annual report for shareholders

The Cardinal Health 2014 digital report to shareholders is now available. Interested parties can learn about the company's fiscal year performance and how Cardinal Health is supporting the health care continuum by accessing the report at http://cardinalhealth.com/annualreport.

1 Oct 2014

M.E.D. Surgical to market GBUK’s products across Republic of Ireland, Northern Ireland

GBUK Ltd has announced that it has agreed an exclusive distribution deal which will see M.E.D. Surgical represent the company across the Republic of Ireland and Northern Ireland.

1 Oct 2014

Hercules Technology Growth Capital issues advance payment to Alimera Sciences

Alimera Sciences, Inc. (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it has received a $25 million advance from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules).

1 Oct 2014

IBM extends multiyear services agreement with AmerisourceBergen

IBM (NYSE: IBM) today announced that it has extended, by three years, its multiyear services agreement with AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution services companies in the world.

1 Oct 2014

Dandrit Biotech A/S Signs Agreement To Commence Clinical Trials Of Melcancervac®

DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.

30 Sep 2014

Allakos secures additional $10M investment to expand its development portfolio

Allakos Inc. announced today that it has secured an additional $10 million investment from current investors to fund development of an additional therapeutic antibody.

30 Sep 2014

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

Acutus Medical, Inc. (ACM), a medical device company developing a minimally invasive real-time 3D Cardiac Chamber Imaging and Dipole Density Mapping system to identify the sources that cause and / or sustain complex cardiac arrhythmias, including atrial fibrillation, announced it has completed an additional $26.2M financing to continue developing its imaging/mapping system as well as bring to market a complete product portfolio.

30 Sep 2014

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Johnson & Johnson today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

30 Sep 2014

Business / Finance

NorthStar Healthcare invests over $170M In two healthcare real estate transactions

Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Cardiac Dimensions adds $8.5M to its previously announced financing

COMS Interactive, PointRight partner to integrate advanced clinical services and predictive analytics

Cognizant announces acquisition of Cadient Group

SynGen announces securement of additional financing from San Francisco-based life sciences venture capital firm

Bitplane and microDimensions announce partnership to bring Voloom to the wider life sciences market

BioCap conference showcased life sciences companies in the North

Sigma-Aldrich enters into agreement to acquire Cell Marque to better serve IHC customers

Cepheid to acquire LABSCO's customer relationships for $21M

Ganymed, BioNTech AG open new headquarters and research facility in Germany

GSK awards milestone payment to Isis Pharmaceuticals to develop ISIS-GSK4Rx for ocular disease

Cardinal Health releases 2014 digital report and annual report for shareholders

M.E.D. Surgical to market GBUK’s products across Republic of Ireland, Northern Ireland

Hercules Technology Growth Capital issues advance payment to Alimera Sciences

IBM extends multiyear services agreement with AmerisourceBergen

Dandrit Biotech A/S Signs Agreement To Commence Clinical Trials Of Melcancervac®

Allakos secures additional $10M investment to expand its development portfolio

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Latest News